Goldman Sachs
ANGO icon

Goldman Sachs’s AngioDynamics ANGO Stock Holding History

Goldman Sachs’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-81,700
Closed -$1.12M – 7099
2014
Q3 		$1.12M Buy
+81,700
New +$1.17M ﹤0.01% 4486

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Goldman Sachs's ANGO Position: Q1 2026 in Review

Goldman Sachs reduced its AngioDynamics (ANGO) stake by 0.73% in Q1 2026, selling an estimated $24.9K and leaving 314,089 shares worth $3.57M. The position accounts for ﹤0.01% of the portfolio, ranked #4014.

Goldman Sachs first reported a position in ANGO in Q2 2013 and has held it in 51 quarters since. The position peaked at $12.8M in Q4 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Goldman Sachs held 314,089 shares of AngioDynamics worth $3.57M as of Q1 2026.
  • Goldman Sachs sold 2,300 AngioDynamics shares in Q1 2026, an estimated $24.9K.
  • AngioDynamics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4014 holding.
  • Goldman Sachs first reported a position in AngioDynamics in Q2 2013 and has held it in 51 quarters since.
  • Goldman Sachs's AngioDynamics position peaked at $12.8M in Q4 2021.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.